Table of Content

1. Introduction


2. Research & Methodology


3. Executive Summary


4. Market Dynamics

4.1 Growth Drivers
4.2 Challenges


5. Australia Diabetes Market


6. Australia Diabetes Population

6.1 Type 1 Diabetes
6.2 Type 2 Diabetes


7. Market Share – Australia Diabetes Analysis

7.1 By Types


8. Continuous Glucose Monitoring Market (CGM) – Market & Users

8.1 CGM Market by Components

8.1.1 Glucose Sensor Market
8.1.2 CGM Transmitter Market

8.2 CGM User
8.3 Reimbursement Policies of CGM Devices in Australia


9. Blood Glucose Device (SMBG) – Australia Market & Users

9.1 Market

9.1.1 Type 1 Diabetes Market
9.1.2 Type 2 Diabetes Market

9.2 Test Strips Market

9.2.1 Type 1 Diabetes
9.2.2 Type 2 Diabetes

9.3 Lancet Market

9.3.1 Type 1 Diabetes
9.3.2 Type 2 Diabetes

9.4 Meter Market and Forecast

9.4.1 Type 1 Diabetes
9.4.2 Type 2 Diabetes

9.5 Blood Glucose (SMBG) Users

9.5.1 Type 1 Diabetes
9.5.2 Type 2 Diabetes

9.6 Reimbursement Policies of Blood Glucose Devices in Australia


10. Insulin Pen – Australia Market & User Analysis

10.1 Insulin Pen Market

10.1.1 Disposable Insulin Pen Market
10.1.2 Reusable Insulin Pen Market
10.1.3 Smart Insulin Pen Market

10.2 Insulin Pen User

10.2.1 Disposable Insulin Pen User
10.2.2 Reusable Insulin Pen User
10.2.3 Smart Insulin Pen User

10.3 Insulin Pen Needle Market
10.4 Reimbursement Policies of Insulin Pen in Australia


11. Insulin Pump – Australia Market & Users

11.1 Insulin Pump Market

11.1.1 Type 1 Diabetes Market
11.1.2 Type 2 Diabetes Market

11.2 Insulin Pump User

11.2.1 Type 1 Insulin Pump User
11.2.2 Type 2 Insulin Pump User

11.3 Differentiation Points of Insulin Pump Products in Australia

11.3.1 Animas Vibe
11.3.2 Medtronic 530G with Enlite
11.3.3 Insulet OmniPod
11.3.4 Tandem t: slim
11.3.5 Roche Accu-Chek Combo

11.4 Training Model for Patients & HCP – of Medtronic, Animas, Insulet Corp & Tandem Diabetes Care

11.4.1 Medtronic

11.5 Insulet Corporation

11.5.1 Training Structure for New Patients - Insulet Corporation

11.6 Animas Corporation

11.6.1 Training Modules for New Patients
11.6.2 Training Modules for HCP (Health Care Professional)

11.7 Tandem Diabetes Care
11.8 Reimbursement Policies Insulin Pump


12. Insulin Pen – Company Analysis

12.1 B. Braun Melsungen AG

12.1.1 Overview
12.1.2 Recent Developments
12.1.3 Revenue

12.2 Eli Lilly

12.2.1 Overview
12.2.2 Recent Developments
12.2.3 Revenue

12.3 Terumo Corporation

12.3.1 Overview
12.3.2 Recent Developments
12.3.3 Revenue

12.4 BD

12.4.1 Overview
12.4.2 Recent Developments
12.4.3 Revenue

12.5 Novo Nordisk A/S

12.5.1 Overview
12.5.2 Recent Developments
12.5.3 Revenue

12.6 Ypsomed AG

12.6.1 Overview
12.6.2 Recent Developments
12.6.3 Revenue


13. Insulin Pump – Company Analysis

13.1 Medtronic

13.1.1 Overview
13.1.2 Recent Developments
13.1.3 Revenue

13.2 Insulet Corporation

13.2.1 Overview
13.2.2 Recent Developments
13.2.3 Revenue


14. SMBG – Company Analysis

14.1 LifeScan Inc.

14.1.1 Overview
14.1.2 Recent Developments
14.1.3 Revenue

14.2 Abbott Laboratories

14.2.1 Overview
14.2.2 Recent Developments
14.2.3 Revenue


15. CGM – Company Analysis

15.1 Dexcom Inc

15.1.1 Overview
15.1.2 Recent Developments
15.1.3 Revenue

15.2 Roche

15.2.1 Overview
15.2.2 Recent Developments
15.2.3 Revenue

15.3 Tandem Diabetes Care

15.3.1 Overview
15.3.2 Recent Developments
15.3.3 Revenue



List of Figures

Figure-01: Australia – Diabetes Market (Billion US$), 2017 – 2022
Figure-02: Australia – Forecast for Diabetes Market (Billion US$), 2023 – 2028
Figure-03: Australia – Type 1 Diabetes Population (Thousand), 2017 – 2022
Figure-04: Australia – Forecast for Type 1 Diabetes Population (Thousand), 2023 – 2028
Figure-05: Australia – Type 2 Diabetes Population (Thousand), 2017 – 2022
Figure-06: Australia – Forecast for Type 2 Diabetes Population (Thousand), 2023 – 2028
Figure-07: Australia – Glucose Sensor Market (Million US$), 2017 – 2023
Figure-08: Australia – Forecast for Glucose Sensor Market (Million US$), 2023 – 2028
Figure-09: Australia – CGM Transmitter Market (Million US$), 2017 – 2023
Figure-10: Australia – Forecast for CGM Transmitter Market (Million US$), 2023 – 2028
Figure-11: Australia – CGM User (Thousand), 2017 – 2023
Figure-12: Australia – Forecast for CGM User (Thousand), 2023 – 2028
Figure-13: Australia – Self-Monitoring of Blood Glucose (SMBG) Type 1 Diabetes Market (Million US$), 2023 – 2028
Figure-14: Australia – Forecast for Self-Monitoring of Blood Glucose (SMBG) Type 1 Diabetes Market (Million US$), 2017 – 2023
Figure-15: Australia – Self-Monitoring of Blood Glucose (SMBG) Type 2 Diabetes Market (Million US$), 2023 – 2028
Figure-16: Australia – Forecast for Self-Monitoring of Blood Glucose (SMBG) Type 2 Diabetes Market (Million US$), 2017 – 2023
Figure-17: Australia – Test Strips Type 1 Diabetes Market (Million US$), 2023 – 2028
Figure-18: Australia – Forecast for Test Strips Type 1 Diabetes Market (Million US$), 2017 – 2023
Figure-19: Australia – Test Strips Type 2 Diabetes Market (Million US$), 2023 – 2028
Figure-20: Australia – Forecast for Test Strips Type 2 Diabetes Market (Million US$), 2017 – 2023
Figure-21: Australia – Lancet Type 1 Diabetes Market (Million US$), 2023 – 2028
Figure-22: Australia – Forecast for Lancet Type 1 Diabetes Market (Million US$), 2017 – 2023
Figure-23: Australia – Lancet Type 2 Diabetes Market (Million US$), 2023 – 2028
Figure-24: Australia – Forecast for Lancet Type 2 Diabetes Market (Million US$), 2017 – 2023
Figure-25: Australia – Meter Type 1 Diabetes Market (Million US$), 2023 – 2028
Figure-26: Australia – Forecast for Meter Type 1 Diabetes Market (Million US$), 2017 – 2023
Figure-27: Australia – Meter Type 2 Diabetes Market (Million US$), 2023 – 2028
Figure-28: Australia – Forecast for Meter Type 2 Diabetes Market (Million US$), 2017 – 2023
Figure-29: Australia – Self-Monitoring of Blood Glucose (SMBG) Type 1 Users (Thousand), 2017 – 2022
Figure-30: Australia – Forecast for Self-Monitoring of Blood Glucose (SMBG) Type 1 Users (Thousand), 2023 – 2028
Figure-31: Australia – Self-Monitoring of Blood Glucose (SMBG) Type 2 Users (Thousand), 2017 – 2022
Figure-32: Australia – Forecast for Self-Monitoring of Blood Glucose (SMBG) Type 2 Users (Thousand), 2023 – 2028
Figure-33: Australia – Disposable Insulin Pen Market (Million US$), 2017 – 2023
Figure-34: Australia – Forecast for Disposable Insulin Pen Market (Million US$), 2023 – 2028
Figure-35: Australia – Reusable Insulin Pen Market (Million US$), 2017 – 2023
Figure-36: Australia – Forecast for Reusable Insulin Pen Market (Million US$), 2023 – 2028
Figure-37: Australia – Smart Insulin Pen Market (Million US$), 2017 – 2023
Figure-38: Australia – Forecast for Smart Insulin Pen Market (Million US$), 2023 – 2028
Figure-39: Australia – Disposable Insulin Pen User (Thousand), 2017 – 2022
Figure-40: Australia – Forecast for Disposable Insulin Pen User (Thousand), 2023 – 2028
Figure-41: Australia – Reusable Insulin Pen User (Thousand), 2017 – 2022
Figure-42: Australia – Forecast for Reusable Insulin Pen User (Thousand), 2023 – 2028
Figure-43: Australia – Smart Insulin Pen User (Thousand), 2017 – 2022
Figure-44: Australia – Forecast for Smart Insulin Pen User (Thousand), 2023 – 2028
Figure-45: Australia – Insulin Pen Needle Market (Million US$), 2017 – 2023
Figure-46: Australia – Forecast for Pen Needle Market (Million US$), 2023 – 2028
Figure-47: Australia – Insulin Pump Market for Type 1 Diabetes Market (Million US$), 2017 – 2023
Figure-48: Australia – Forecast for Insulin Pump Market for Type 1 Diabetes Market (Million US$), 2023 – 2028
Figure-49: Australia – Insulin Pump Market for Type 2 Diabetes Market (Million US$), 2017 – 2023
Figure-50: Australia – Forecast for Insulin Pump Market for Type 2 Diabetes Market (Million US$), 2023 – 2028
Figure-51: Australia – Insulin Pump Type 1 Users (Thousand), 2017 – 2022
Figure-52: Australia – Forecast for Insulin Pump Type 1 Users (Thousand), 2023 – 2028
Figure-53: Australia – Insulin Pump Type 2 Users (Thousand), 2017 – 2022
Figure-54: Australia – Forecast for Insulin Pump Type 2 Users (Thousand), 2023 – 2028
Figure-55: B. Braun Melsungen AG – Global Revenue (Billion US$), 2017 – 2022
Figure-56: B. Braun Melsungen AG – Forecast for Global Revenue (Billion US$), 2023 – 2028
Figure-57: Eli Lilly – Global Revenue (Million US$), 2017 – 2022
Figure-58: Eli Lilly – Forecast for Global Revenue (Million US$), 2023 – 2028
Figure-59: Terumo Corporation – Global Revenue (Billion US$), 2017 – 2022
Figure-60: Terumo Corporation – Forecast for Global Revenue (Billion US$), 2023 – 2028
Figure-61: BD – Global Revenue (Billion US$), 2017 – 2022
Figure-62: BD – Forecast for Global Revenue (Billion US$), 2023 – 2028
Figure-63: Novo Nordisk A/S – Global Revenue (Million US$), 2017 – 2022
Figure-64: Novo Nordisk A/S – Forecast for Global Revenue (Million US$), 2023 – 2028
Figure-65: Ypsomed AG – Global Revenue (Million US$), 2017 – 2022
Figure-66: Ypsomed AG – Forecast for Global Revenue (Million US$), 2023 – 2028
Figure-67: Medtronic – Global Revenue (Billion US$), 2017 – 2022
Figure-68: Medtronic – Forecast for Global Revenue (Billion US$), 2023 – 2028
Figure-69: Insulet Corporation – Global Revenue (Million US$), 2017 – 2022
Figure-70: Insulet Corporation – Forecast for Global Revenue (Million US$), 2023 – 2028
Figure-71: DarioHealth Corp – Global Revenue (Million US$), 2017 – 2022
Figure-72: DarioHealth Corp – Forecast for Global Revenue (Million US$), 2023 – 2028
Figure-73: Abbott Laboratories – Global Revenue (Billion US$), 2017 – 2022
Figure-74: Abbott Laboratories – Forecast for Global Revenue (Billion US$), 2023 – 2028
Figure-75: Dexcom Inc – Global Revenue (Billion US$), 2017 – 2022
Figure-76: Dexcom Inc – Forecast for Global Revenue (Billion US$), 2023 – 2028
Figure-77: Roche – Global Revenue (Billion US$), 2017 – 2022
Figure-78: Roche – Forecast for Global Revenue (Billion US$), 2023 – 2028
Figure-79: Tandem Diabetes Care – Global Revenue (Million US$), 2017 – 2022
Figure-80: Tandem Diabetes Care – Forecast for Global Revenue (Million US$), 2023 – 2028

List of Tables

Table-01: Australia – Diabetes Market Share by Type (Percent), 2017 – 2022
Table-02: Australia – Forecast for Diabetes Market Share by Type (Percent), 2023 – 2028